[HTML][HTML] A randomized study of alglucosidase alfa in late-onset Pompe's disease

…, J Florence, GJ Groeneveld, S Herson… - … England Journal of …, 2010 - Mass Medical Soc
Background Pompe's disease is a metabolic myopathy caused by a deficiency of acid alpha
glucosidase (GAA), an enzyme that degrades lysosomal glycogen. Late-onset Pompe's …

Long-term observational study of sporadic inclusion body myositis

…, T Stojkovic, MI Leite, Y Allenbach, S Herson… - Brain, 2011 - academic.oup.com
We describe a long-term observational study of a large cohort of patients with sporadic
inclusion body myositis and propose a sporadic inclusion body myositis weakness composite …

Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin

…, P Cacoub, L Arnaud, B Grosbois, S Herson… - Medicine, 2014 - journals.lww.com
Necrotizing autoimmune myopathy (NAM) is a group of acquired myopathies characterized
by prominent myofiber necrosis with little or no muscle inflammation. Recently, researchers …

Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: an open study with 20 adult patients

P Cherin, S Herson, B Wechsler, JC Piette… - The American journal of …, 1991 - Elsevier
purpose: Polymyositis and dermatomyositis are inflammatory muscular diseases of unknown
cause. Many interventions are available to treat patients with these conditions including …

Correlation of anti–signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy

…, B Eymard, D Gilbert, F Tron, S Herson… - Arthritis & …, 2011 - Wiley Online Library
Objective Anti–signal recognition particle (anti‐SRP) autoantibodies are associated with
severe acquired necrotizing myopathies. The role of these autoantibodies remains elusive, and …

Opportunistic infections in polymyositis and dermatomyositis

…, P Chérin, MF Hellot, S Herson… - Arthritis Care & …, 2005 - Wiley Online Library
Objective To assess prevalence and characteristics of opportunistic infections in patients
with polymyositis/dermatomyositis (PM/DM). To determine the predictive values for …

Phase I study of dystrophin plasmid-based gene therapy in Duchenne/Becker muscular dystrophy

…, JG Guillet, P Squiban, S Herson… - Human gene …, 2004 - liebertpub.com
Nine patients with Duchenne or Becker muscular dystrophy were injected via the radialis
muscle with a full-length human dystrophin plasmid, either once with 200 or 600 µg of DNA or …

[HTML][HTML] Efficacy of rituximab in refractory inflammatory myopathies associated with anti-synthetase auto-antibodies: an open-label, phase II trial

…, P Grenier, H Devilliers, A Hij, O Boyer, S Herson… - PloS one, 2015 - journals.plos.org
Objective Anti-synthetase syndrome (anti-SS) is frequently associated with myositis and
interstitial lung disease (ILD). We evaluated prospectively, in a multicenter, open-label, phase II …

Magnetic resonance imaging criteria for distinguishing between inclusion body myositis and polymyositis.

…, O Chosidow, P Godeau, JC Piette, S Herson… - The Journal of …, 2002 - jrheum.org
OBJECTIVE: To develop diagnostic imaging criteria for polymyositis (PM) and sporadic
inclusion body myositis (sIBM). METHODS: We investigated 220 patients with suspected …

Temporal artery biopsy: a diagnostic tool for systemic necrotizing vasculitis

…, P Roblot, JH Barrier, S Herson… - … : Official Journal of …, 1999 - Wiley Online Library
Objective To describe the clinical, biologic, and histologic features of temporal artery biopsy
(TAB)–localized systemic necrotizing vasculitides (SNV), and to assess their frequency …